ALBERTELLI, MANUELA
 Distribuzione geografica
Continente #
EU - Europa 7.901
AS - Asia 902
NA - Nord America 631
SA - Sud America 83
AF - Africa 15
OC - Oceania 2
Totale 9.534
Nazione #
IT - Italia 7.765
US - Stati Uniti d'America 599
SG - Singapore 351
CN - Cina 256
VN - Vietnam 164
FR - Francia 60
BR - Brasile 55
BD - Bangladesh 42
HK - Hong Kong 26
AR - Argentina 14
CA - Canada 13
DE - Germania 13
GB - Regno Unito 12
MX - Messico 12
FI - Finlandia 10
JP - Giappone 9
ID - Indonesia 7
IE - Irlanda 6
IQ - Iraq 6
NL - Olanda 6
ZA - Sudafrica 6
CH - Svizzera 5
IN - India 5
TR - Turchia 5
PK - Pakistan 4
CO - Colombia 3
EC - Ecuador 3
JO - Giordania 3
LB - Libano 3
OM - Oman 3
PH - Filippine 3
RU - Federazione Russa 3
TH - Thailandia 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
CL - Cile 2
ES - Italia 2
JM - Giamaica 2
LT - Lituania 2
MY - Malesia 2
NP - Nepal 2
PL - Polonia 2
RO - Romania 2
SE - Svezia 2
TN - Tunisia 2
VE - Venezuela 2
AL - Albania 1
AT - Austria 1
AU - Australia 1
BE - Belgio 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
KE - Kenya 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LV - Lettonia 1
MA - Marocco 1
MM - Myanmar 1
MQ - Martinica 1
MU - Mauritius 1
NG - Nigeria 1
PE - Perù 1
PY - Paraguay 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
WS - Samoa 1
Totale 9.534
Città #
Genova 3.658
Genoa 2.693
Vado Ligure 709
Rapallo 595
San Jose 200
Singapore 156
Ashburn 58
Lauterbourg 55
Beijing 52
Hanoi 38
Ho Chi Minh City 37
Council Bluffs 34
New York 29
Hong Kong 24
Bordighera 19
Rome 15
Los Angeles 13
Boardman 12
Santa Clara 12
Atlanta 11
Chicago 11
Frankfurt am Main 10
Haiphong 9
Helsinki 8
Mexico City 8
Orem 8
São Paulo 8
Tokyo 8
Da Nang 7
Milan 6
Turin 6
Bologna 5
Dublin 5
Zurich 5
Biên Hòa 4
Buffalo 4
Cardiff 4
Dallas 4
Des Moines 4
Houston 4
London 4
Montreal 4
Shanghai 4
Amman 3
Amsterdam 3
Bangkok 3
Buenos Aires 3
Curitiba 3
Memphis 3
Phoenix 3
Quận Ba 3
Thái Bình 3
Thái Nguyên 3
Trieste 3
Arlington 2
Baghdad 2
Blumenau 2
Borgosesia 2
Brasília 2
Caracas 2
Chennai 2
City of London 2
Denver 2
Fayetteville 2
Florence 2
Fortaleza 2
Johannesburg 2
Karachi 2
Karbala 2
Kingston 2
Lappeenranta 2
Miami 2
Naples 2
North Port 2
Nuremberg 2
Palermo 2
Porto Alegre 2
Queens 2
Rovolon 2
Secaucus 2
Seeb 2
St Louis 2
Stockholm 2
Tianjin 2
Toronto 2
Việt Trì 2
Vĩnh Long 2
Vĩnh Tường 2
Warsaw 2
Điện Bàn 2
Abington 1
Acalanes Ridge 1
Addis Ababa 1
Albuquerque 1
Almere Stad 1
Altamura 1
Ankara 1
Apia 1
Arapiraca 1
Arlington Heights 1
Totale 8.675
Nome #
Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs? 236
Autonomic nervous system and cardiovascular risk assessment during one year of growth hormone (GH) replacement therapy in adults with GH deficiency. 233
Current perspectives in obesity management: unraveling the impact of different therapy approach in real life obesity care 226
Anti-tumoral effects of somatostatin analogs: a lesson from the CLARINET study 221
SOMATOSTATIN AND DOPAMINE RECEPTOR INTERACTION IN PROSTATE AND LUNG CANCER CELL LINES 211
Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system 209
Diabetes secondary to neuroendocrine gastroenteropancreatic tumors 208
Autoimmune central diabetes insipidus in a patient with ureaplasma urealyticum infection and review on new triggers of immune response. 207
Dipeptidyl peptidase-4 inhibitors do not alter GH/IGF-I axis in adult diabetic patients 189
"Present and future of immunotherapy in Neuroendocrine Tumors" 184
Emerging targets in pituitary adenomas: role of the CXCL12/CXCR4-R7 system 183
Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms 182
Preclinical and clinical experiences with the role of dopamine receptors in the treatment of pituitary adenomas 181
Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growth. 181
Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors 176
Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives 176
KI-67 heterogeneity in well differentiated gastro-entero-pancreatic neuroendocrine tumors: when is biopsy reliable for grade assessment ? 174
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? 170
One-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patients 169
Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation 165
Grade increases in gastroenteropancreatic neuroendocrine tumor metastases compared to the primary tumor 163
Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study 158
Current perspectives on the impact of clinical disease and biochemical control on comorbidities and quality of life in acromegaly 157
Doe4s biopsy reliably identify grade in gastro-entero-pancreatic neuroendocrine tumors? 156
Twenty years of gastroenteropancreatic neuroendocrine tumors: is reclassification worthwhile and feasible? 153
Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetes 152
Ectopic Cushing and other paraneoplastic syndromes in thoracic neuroendocrine tumors 151
Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures 149
Role of dopamine receptors in normal and tumoral pituitary corticotropic cells and adrenal cells 146
Neuroendocrine tumors: insights into innovative therapeutic options and rational development of targeted therapies 144
The treatment of hyperinsulinemic hypoglycaemia in adults: an update 142
Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study 136
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study 134
Ten years of gastroeneteropancreatic neuroendocrine tumors: is reclassification Worth while? 131
Potential indications for somatostatin analogues: immune system and lymphoproliferative disorders 130
A tool to predict survival in stage IV entero-pancreatic NEN 128
Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study 127
Escalated-dose somatostatin analogues for antiproliferative effect in GEPNETS: a systematic review 126
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study 124
PD-L1 expression, BRAF and TERT mutation in a cohort of aggressive thyroid cancers: case series from a single-centre experience 123
Does biopsy reliably identify grade in gastro-entero-pancreatic neuroendocrine tumors? 123
Ki-67 heterogeneity in gastroenteropancreatic neuroendocrine tumors 123
Body Composition and Bone Status in Relation to Microvascular Damage in Systemic Sclerosis Patients 123
Modulatory activity of testosterone on growth pattern and IGF-1 levels in vanishing testis syndrome: a case report during 15 years of follow-up 121
Hormone and Receptor Candidates for Target and Biotherapy of Neuroendocrine Tumors 118
GOSAFE - Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery: early analysis on 977 patients 115
2-[18 F]FDG PET in the Management of Radioiodine Refractory Differentiated Thyroid Cancer in the Era of Thyrosin-Kinases Inhibitors: A Real-Life Retrospective Study 111
An unusual cause of adrenal insufficiency with elevation of 17-hydroxyprogesterone: case report 110
null 110
Impact of microscopic extrathyroidal extension on differentiated thyroid cancer post-surgical risk of recurrence: a retrospective analysis 106
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective 100
The effect of sodium restriction on iodine prophylaxis: a review 99
The impact of overweight on lipid phenotype in different forms of dyslipidemia: a retrospective cohort study 98
GH Replacement in the Elderly: Is It Worth It? 98
Insights into mechanisms of tumorigenesis in neuroendocrine neoplasms 98
Primary hyperparathyroidism in patients with thyroid cancer: prevalence and prognosis in a retrospective monocentric study 92
PRRT: identikit of the perfect patient 91
Prevalence of Lactose Intolerance in Patients with Hashimoto Thyroiditis and Impact on LT4 Replacement Dose 87
Sodium Intake and Target Organ Damage in Hypertension-An Update about the Role of a Real Villain 86
Erratum to: KI-67 heterogeneity in well differentiated gastro-entero-pancreatic neuroendocrine tumors: when is biopsy reliable for grade assessment? (Endocrine, (2017), 57, 3, (494-502), 10.1007/s12020-017-1364-8) 83
Nuove potenziali applicazioni degli analoghi della somatostatina 78
Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies 75
Trabecular Bone Score as a Reliable Measure of Lumbar Spine Bone Microarchitecture in Acromegalic Patients 73
Possible protective role of metformin therapy on colonic polyps in acromegaly: An exploratory cross-sectional study 69
Potential indications for somatostatin analogues: immune system and limphoproliferative disorders 68
Nonconventional Doses of Somatostatin Analogs in Patients with Progressing Well-Differentiated Neuroendocrine Tumor 68
Prognostic features of gastro-entero-pancreatic neuroendocrine neoplasms in primary and metastatic sites: Grade, mesenteric tumour deposits and emerging novelties 59
Prognostic Effect of Lymph Node Metastases and Mesenteric Deposits in Neuroendocrine Tumors of the Small Bowel 59
Rectal mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN): High grade evolution of a MANET? 59
Off-label pasireotide treatment in one insulinoma patient with an atypical presentation and intolerant to diazoxide 58
null 57
Bone metastases in neuroendocrine neoplasms: From pathogenesis to clinical management 56
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 56
Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to Ask 42
Somatostatin receptor pathophysiology in the neuroendocrine system 23
Improved overall survival in patients developing endocrine toxicity during treatment with nivolumab for advanced non-small cell lung cancer in a prospective study 19
Open issues on G3 neuroendocrine neoplasms: Back to the future 19
The diagnostic and prognostic role of combined [18F]FDG and [68Ga]-DOTA-peptides PET/CT in primary pulmonary carcinoids: a multicentric experience 16
Totale 9.757
Categoria #
all - tutte 32.750
article - articoli 32.182
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 568
Totale 65.500


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128 0 0 0 0 0 0 0 0 0 0 0 28
2021/2022661 37 22 39 80 12 70 24 154 52 70 21 80
2022/2023717 68 81 15 54 93 97 16 62 114 8 101 8
2023/2024528 26 69 6 66 39 96 39 30 13 31 45 68
2024/20251.784 51 96 56 139 239 180 205 287 51 89 178 213
2025/20262.927 354 115 414 242 343 216 370 117 247 243 196 70
Totale 9.757